Riti Desai
London, ENG SE59RS, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Stereotactic radiotherapy for neovascular age related macular degeneration: year 3 and 4 extended follow up results of a randomised, double masked, sham controlled, device trial (STAR).
Journal: BMJ (Clinical research ed.)
Published: June 18, 2026
EQ-5D vision bolt-on in macular degeneration: associations with visual measures and effect on utility differences and cost-effectiveness of stereotactic radiotherapy.
Journal: Health and quality of life outcomes
Published: August 07, 2025
Stereotactic radiotherapy for nAMD: areas for improvement - Authors' reply.
Journal: Lancet (London, England)
Published: January 23, 2025
Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): update to study protocol and addition of a statistical analysis plan and health economic analysis plan for a randomised controlled surgical trial.
Journal: Trials
Published: December 11, 2023
Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial.
Journal: Lancet (London, England)
Published: November 30, 2023
Epimacular brachytherapy for previously treated neovascular age-related macular degeneration: month 36 results of the MERLOT randomised controlled trial.
Journal: The British journal of ophthalmology
Published: October 12, 2021
Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial.
Journal: Trials
Published: April 18, 2021
Evaluation of Month-24 Efficacy and Safety of Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration: The MERLOT Randomized Clinical Trial.
Journal: JAMA ophthalmology
Published: July 10, 2020
Intravitreal ranibizumab for persistent diabetic vitreous haemorrhage: a randomised, double-masked, placebo-controlled feasibility study.
Journal: Acta ophthalmologica
Published: May 07, 2019
Intravitreal gas for symptomatic vitreomacular adhesion: a synthesis of the literature.
Journal: Acta ophthalmologica
Published: March 02, 2017
Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT): A Phase 3 Randomized Controlled Trial.
Journal: Ophthalmology
Published: February 02, 2016
StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial.
Journal: Trials
Published: December 11, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026